Related Experiment Video
Updated: Aug 8, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Ampicillin-specific rashes
1Department of Family Medicine, University of Alabama School of Medicine at Tuscaloosa, USA.
Abstract:
Ampicillin is one of the most common drugs to elicit a rash, with an overall incidence of 3% to 8%. "Ampicillin-specific" rashes are thought to be nonhypersensitivity reactions and cause maculopapular erythema with minimal irritation or pruritus. If the rash is indeed an ampicillin-specific one, then discontinuation of ampicillin is not mandatory, and subsequent use of ampicillin or other beta-lactam antibiotics is tolerated. On the other hand, true hypersensitivity reactions with urticarial and anaphylactic properties demand prompt discontinuation of the drug and warrant supportive care. Unfortunately, there is no immediate definitive scientific method to differentiate between the two.
Insights
Ampicillin rashes occur in 3-8% of patients. Differentiating non-hypersensitivity rashes from true allergic reactions is crucial for continued ampicillin use.
Area of Science:
- Pharmacology
- Clinical Medicine
- Immunology
Background:
- Ampicillin frequently causes skin rashes, affecting 3% to 8% of individuals.
- Distinguishing ampicillin-induced rashes is critical for patient management and antibiotic therapy.
- "Ampicillin-specific" rashes are non-hypersensitivity reactions, while true hypersensitivity reactions present with urticarial and anaphylactic features.
Purpose of the Study:
- To review the characteristics of ampicillin-induced rashes.
- To highlight the clinical implications of differentiating non-hypersensitivity from hypersensitivity reactions.
- To underscore the challenge in definitively distinguishing between these two types of ampicillin rashes.
Main Methods:
- Review of existing literature on ampicillin-induced dermatological reactions.
- Analysis of clinical presentations differentiating non-hypersensitivity and hypersensitivity ampicillin rashes.
- Discussion of management strategies based on rash characteristics.
Main Results:
- Ampicillin-specific rashes manifest as maculopapular erythema with minimal pruritus or irritation.
- True hypersensitivity reactions involve urticaria and potential anaphylaxis, necessitating drug cessation.
- Current scientific methods lack the immediacy to definitively differentiate between these rash types.
Conclusions:
- Prompt identification of ampicillin hypersensitivity is vital for patient safety.
- Non-hypersensitivity ampicillin rashes may permit continued antibiotic therapy and future beta-lactam use.
- Further research is needed to develop definitive diagnostic tools for ampicillin-induced rashes.
More Related Videos
07:10Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
Published on: April 21, 2019
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Staphylococcal Skin Infections
Rocky Mountain Spotted Fever
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Hypersensitivity Reactions: Immune-Complex Reactions